| [1] |
Don M, Canciani M, Korppi M. Community-acquired pneumonia in children: what's old? What's new? [J]. Acta Pediatr, 2010, 99 (11):1602–1608.
|
| [2] |
Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality : an updated systematic analysis for 2010 with time trends since 2000 [J]. Lancet, 2012, 379 (9832): 2151–2161.
|
| [3] |
Li A, Newall AT, Britt H, et al. The cost and disease burden of pneumonia in general practice in Australia [J]. Vaccine, 2012, 30(5)：830–831.
|
| [4] |
中华医学会儿科分会呼吸学组，《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南（试行）（上）[J].中华儿科杂志，2007, 45 (2) : 83–90.
|
| [5] |
中华医学会儿科分会呼吸学组，《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南（试行）（下）[J].中华儿科杂志，2007，45 (3): 223–230.
|
| [6] |
中华医学会儿科分会呼吸学组，《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南（2013修订）（上）[J].中华儿科杂志，2013, 51(10) : 745–752.
|
| [7] |
中华医学会儿科分会呼吸学组，《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南（2013修订）（下）[J].中华儿科杂志，2013, 51(11) : 856–862.
|
| [8] |
Harris M, Clark J, Coote N, et al. British thoracic society guidelines for the management of community acquired pneumonia in children : update 2011 [J]. Thorax, 2011, 66 (Suppl 2) :ii1–ii23.
|
| [9] |
Oxford Centre. Levels of evidence and grades of recommendations [DB/OL]. Center for Evidence Based Medicine––levels of evidemce, 2009, 3. [2013-05-09].
URL
|
| [10] |
Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia [J]. Lancet, 2011, 377(9773): 1264–1275.
|
| [11] |
Garcia-Garcia ML，Calvo C，Pozo F，et al. Spectrum of respiratory viruses in children with community-acquired pneumonia [J]. Pediatr Infect Dis J, 2012, 3l (8): 808–813.
|
| [12] |
Luo Z, Luo J, Liu E, et al. Effects of prednisolone on refractory Mycoplasma pneumoniae in children [J]. Pediatr Pulmonol, 2014, 49(4):377–380.
|
| [13] |
刘金荣，彭芸，杨海明，等.难治性肺炎支原体肺炎的表现特征和判断指标探讨[J].中华儿科杂志，2012，50(12)：915–918.
|
| [14] |
Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America [J]. Clin Infect Dis, 2011, 53(7): e25–e76.
|
| [15] |
Suren P, Try K, Eriksson J, et al. Radiographic follow-up of community-acquired pneumonia in children [J]. Acta Pediatr, 2008, 97(1) : 46–50.
|
| [16] |
Korppi M, Don M, Valent F, et al. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children [J]. Acta Pediatr, 2008, 97 (7): 943–947.
|
| [17] |
Murdoch DR, O'Brien KL, Driscoll AJ, et al. Laboratory methods for determining pneumonia etiology in children [J]. Clin Infect Dis, 2012, 54(Suppl 2): S146–S152.
|
| [18] |
Uehara S, Sunakawa K, Eguchi H, et al. Japanese guidelines for the management of respiratory infectious diseases in children 2007 with focus on pneumonia [J]. Pediatr Int, 2011, 53(2) : 264–276.
|
| [19] |
国家药典委员会.中华人民共和国药典：临床用药须知.2010版[M].北京：人民卫生出版社，2010：729–731.
|
| [20] |
Weinstein MP, Klugman KP, Jones RN. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae : coping with antimicrobial susceptibility in an era of resistance [J]. Clin Infect Dis, 2009, 48(11): 1596–1600.
|
| [21] |
Heinonen S, Silvennoinen H, Lehtinen P, et al. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial [J]. Clin Infect Dis, 2010, 51(8) : 887–894.
|
| [22] |
陆权.疫苗与儿童呼吸道感染性疾病[J].临床儿科杂志，2010，28 (6):513–517.
|